Callan Family Office LLC Has $935,000 Stake in Colgate-Palmolive Company $CL

Callan Family Office LLC trimmed its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 37.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,702 shares of the company’s stock after selling 6,983 shares during the quarter. Callan Family Office LLC’s holdings in Colgate-Palmolive were worth $935,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in CL. Brighton Jones LLC lifted its position in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP raised its stake in Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares during the last quarter. Valmark Advisers Inc. lifted its holdings in Colgate-Palmolive by 2.2% in the second quarter. Valmark Advisers Inc. now owns 10,588 shares of the company’s stock valued at $962,000 after buying an additional 232 shares during the period. Massachusetts Wealth Management boosted its position in Colgate-Palmolive by 1.8% during the second quarter. Massachusetts Wealth Management now owns 12,822 shares of the company’s stock valued at $1,166,000 after acquiring an additional 225 shares during the last quarter. Finally, Maryland State Retirement & Pension System grew its holdings in Colgate-Palmolive by 2.8% during the 2nd quarter. Maryland State Retirement & Pension System now owns 39,075 shares of the company’s stock worth $3,552,000 after acquiring an additional 1,076 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Barclays lifted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a report on Tuesday. Citigroup lifted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday. Piper Sandler increased their target price on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Bank of America raised their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $94.00 price objective on shares of Colgate-Palmolive in a report on Saturday, January 31st. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $94.47.

Colgate-Palmolive Trading Up 0.5%

NYSE:CL opened at $94.84 on Friday. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18. The company has a market cap of $76.45 billion, a PE ratio of 36.20, a PEG ratio of 4.27 and a beta of 0.29. The firm has a 50-day moving average of $81.86 and a 200-day moving average of $81.60.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 EPS. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.